What to expect in the Beam Therapeutics Inc. interview process

Based on publicly available sources, Beam Therapeutics is a publicly traded biotechnology research company founded in 2017, headquartered in Cambridge, Massachusetts, with an additional office in Boston and a facility in Research Triangle Park, North Carolina. The company employs approximately 492 to 522 people and maintains a market cap of around $2.5B.

Public data indicates that Beam operates as a values-driven organization focused on precision genetic medicines and CRISPR base editing technology. The company has received external workplace recognition, ranking No. 4 in the large companies category on the Boston Globe’s Top Places to Work list for 2022 and appearing on the list in prior years. Employee surveys referenced in these awards measure factors such as company direction, execution, connection, management, work, pay and benefits, and engagement.

For roles such as the Product Quality Assurance Specialist in North Carolina, positions may require on-site presence, alternate shift schedules, and direct quality oversight of laboratory and manufacturing operations to ensure compliance as programs transition from clinical to commercial manufacturing. Operational focus areas for the company include internal manufacturing capabilities, ex vivo manufacturing, gene editing, and delivery platforms supporting portfolios like hematology and genetic diseases.